Literature DB >> 2136620

Vascular lesions in the central nervous system in sickle cell disease (neuropathology).

M Koshy1, C Thomas, J Goodwin.   

Abstract

The incidence of serious neurologic complications in sickle cell disease ranges from 6% to 30% in various series. Our experience indicates that the incidence in adults is approximately 15%. The clinical and neuropathologic correlations at autopsy in 20 sickle cell disease patients are discussed in this paper. Some patients had massive infarcts and/or hemorrhages in the cerebral hemispheres as the terminal event. In some, both infarction and hemorrhage occurred simultaneously; others had thrombosis of major branches of the circle of Willis and in the internal carotid artery on one or both sides. Prominent large arterial occlusive disease in the terminal intracranial portions of the internal carotid arteries and proximal segments of their main branches was frequently observed. The pathology of the brain showed diffuse chronic gliotic scars of microinfarcts in the deep white matter and cerebral gray matter, even when no past neurologic history was recorded. We hypothesize that the vague, nonspecific complaints, including chronic alteration of intellectual and emotional function, of some sickle cell disease patients prior to their death, may constitute the clinical counterpart of disseminated microscopic lesions resulting from small-vessel disease. The pathogenesis of vaso-occlusive disease includes altered cerebral blood flow, platelet response to endothelial injury, and sickled erythrocyte adhesion to endothelium.

Entities:  

Mesh:

Year:  1990        PMID: 2136620

Source DB:  PubMed          Journal:  J Assoc Acad Minor Phys        ISSN: 1048-9886


  11 in total

Review 1.  Imaging in childhood arterial ischaemic stroke.

Authors:  Brynmor P Jones; Vijya Ganesan; Dawn E Saunders; W Kling Chong
Journal:  Neuroradiology       Date:  2010-05-06       Impact factor: 2.804

2.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

Review 3.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

4.  Incidental findings on brain magnetic resonance imaging of children with sickle cell disease.

Authors:  Lori C Jordan; Robert C McKinstry; Michael A Kraut; William S Ball; Bruce A Vendt; James F Casella; Michael R DeBaun; John J Strouse
Journal:  Pediatrics       Date:  2010-06-14       Impact factor: 7.124

5.  Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease.

Authors:  Elizabeth A Manci; Cheryl A Hillery; Carol A Bodian; Zheng G Zhang; Gerard A Lutty; Barry S Coller
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

Review 6.  Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.

Authors:  Michael R DeBaun; F Daniel Armstrong; Robert C McKinstry; Russell E Ware; Elliot Vichinsky; Fenella J Kirkham
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

7.  Sickle cell disease with double stroke in a Moroccan family.

Authors:  Khalil Hamzi; Afaf Ben Itto; Zineb Jouhadi; Ilham Slassi; Sellama Nadifi
Journal:  J Mol Neurosci       Date:  2013-01-23       Impact factor: 3.444

8.  Morphological and functional platelet abnormalities in Berkeley sickle cell mice.

Authors:  Arun S Shet; Thomas J Hoffmann; Marketa Jirouskova; Christin A Janczak; Jacqueline R M Stevens; Adewole Adamson; Narla Mohandas; Elizabeth A Manci; Therese Cynober; Barry S Coller
Journal:  Blood Cells Mol Dis       Date:  2008-04-18       Impact factor: 3.039

9.  Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.

Authors:  Kathleen J Helton; Robert J Adams; Karen L Kesler; Alex Lockhart; Banu Aygun; Catherine Driscoll; Matthew M Heeney; Sherron M Jackson; Lakshmanan Krishnamurti; Scott T Miller; Sharada A Sarnaik; William H Schultz; Russell E Ware
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

10.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.